These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38142926)

  • 21. Effect of Roucongrong (Herba Cistanches Deserticolae) decoction on the substantia nigra through Wnt/β-catenin signaling pathway in rats with Parkinson's disease induced by 6-hydroxydopamine hydrochloride.
    Xu Q; Qin W; Wu FZ; Lin Y; Hong LT; Chen D; Hu XF; Cai J
    J Tradit Chin Med; 2021 Oct; 41(5):762-770. PubMed ID: 34708635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
    Jiang J; Piao X; Hu S; Gao J; Bao M
    Aging (Albany NY); 2020 May; 12(10):8820-8836. PubMed ID: 32434961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons.
    Yuan WJ; Yasuhara T; Shingo T; Muraoka K; Agari T; Kameda M; Uozumi T; Tajiri N; Morimoto T; Jing M; Baba T; Wang F; Leung H; Matsui T; Miyoshi Y; Date I
    BMC Neurosci; 2008 Aug; 9():75. PubMed ID: 18671880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders.
    Walia V; Chaudhary SK; Kumar Sethiya N
    Neurochem Int; 2021 Feb; 143():104939. PubMed ID: 33346032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
    Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
    Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
    Luo L; Chen J; Su D; Chen M; Luo B; Pi R; Wang L; Shen W; Wang R
    Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
    Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
    Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetramethylpyrazine Analogue T-006 Exerts Neuroprotective Effects against 6-Hydroxydopamine-Induced Parkinson's Disease
    Zhou H; Shao M; Yang X; Li C; Cui G; Gao C; Di L; Zhong H; Wang Y; Zhang Z; Lee SM
    Oxid Med Cell Longev; 2019; 2019():8169125. PubMed ID: 31827703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway.
    Li Q; Li S; Fang J; Yang C; Zhao X; Wang Q; Zhou W; Zheng W
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway.
    Liu J; Jiang J; Qiu J; Wang L; Zhuo J; Wang B; Sun D; Yu S; Lou H
    Food Funct; 2022 Jan; 13(1):375-385. PubMed ID: 34905594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt/β-catenin signaling plays an essential role in α7 nicotinic receptor-mediated neuroprotection of dopaminergic neurons in a mouse Parkinson's disease model.
    Liu Y; Hao S; Yang B; Fan Y; Qin X; Chen Y; Hu J
    Biochem Pharmacol; 2017 Sep; 140():115-123. PubMed ID: 28551099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective Effects of Paeoniflorin on 6-OHDA-Lesioned Rat Model of Parkinson's Disease.
    Gu XS; Wang F; Zhang CY; Mao CJ; Yang J; Yang YP; Liu S; Hu LF; Liu CF
    Neurochem Res; 2016 Nov; 41(11):2923-2936. PubMed ID: 27447883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
    Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
    Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetramethylpyrazine Analogue CXC195 Protects Against Dopaminergic Neuronal Apoptosis via Activation of PI3K/Akt/GSK3β Signaling Pathway in 6-OHDA-Induced Parkinson's Disease Mice.
    Chen L; Cheng L; Wei X; Yuan Z; Wu Y; Wang S; Ren Z; Liu X; Liu H
    Neurochem Res; 2017 Apr; 42(4):1141-1150. PubMed ID: 28005221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effect of Na
    Xing R; Liu X; Tian B; Cheng Y; Li L
    Drug Dev Res; 2021 Nov; 82(7):969-979. PubMed ID: 33538000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo neuroprotective effect of novel mPGES-1 inhibitor in animal model of Parkinson's disease.
    Yang S; Huh E; Moon GH; Ahn J; Woo J; Han HS; Lee HH; Chung KS; Lee KT; Oh MS; Lee JY
    Bioorg Med Chem Lett; 2022 Oct; 74():128920. PubMed ID: 35931244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
    Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
    Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model.
    Ferreira AFF; Singulani MP; Ulrich H; Feng ZP; Sun HS; Britto LR
    Mol Neurobiol; 2022 Mar; 59(3):1543-1559. PubMed ID: 35000153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.